BEGIN:VCALENDAR VERSION:2.0 PRODID:-//ChamberMaster//Event Calendar 2.0//EN METHOD:PUBLISH X-PUBLISHED-TTL:P3D REFRESH-INTERVAL:P3D CALSCALE:GREGORIAN BEGIN:VTIMEZONE TZID:Eastern Standard Time BEGIN:DAYLIGHT DTSTART:20070101T000000 RRULE:FREQ=YEARLY;BYDAY=2Su;BYMONTH=MM TZOFFSETFROM:-05:00:00 TZOFFSETTO:-04:00:00 TZNAME:Eastern Daylight Time END:DAYLIGHT BEGIN:STANDARD DTSTART:99991231T000000 RRULE:FREQ=YEARLY;BYDAY=1Su;BYMONTH=MM TZOFFSETFROM:-04:00:00 TZOFFSETTO:-05:00:00 TZNAME:Eastern Standard Time END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID="Eastern Standard Time":20190603T063000 DTEND;TZID="Eastern Standard Time":20190603T090000 X-MICROSOFT-CDO-ALLDAYEVENT:FALSE SUMMARY:Advances in Diabetes Care DESCRIPTION:Advances in Diabetes CareJune 3 - Monday\nDiabetes Clinical UpdateNew insights on both Type 1 Diabetes and Type 2 Diabetes from the perspective of a leading clinical researcher. Dr. Gabbay\, the Chief Medical Officer of the Joslin Diabetes Center\, will moderate our program\, and he will provide an overview of the best clinical practices in diabetes care today\, as well as the challenges involved in helping people with diabetes to effectively manage their diabetes.\n\nSmart Devices and WearablesHow connected health is impacting care\, medication and insulin titration and adherence\, and clinical and economic outcomes for payers\, providers\, employers\, etc. James White\, the co-founder of Common Sensing\, a smart insulin pen company\, will describe the advances underway in using real time glucose information to help patients and their care teams to optimize diabetes management to drive better clinical and economic outcomes.\n\nArtificial Pancreas and AIClosed loop systems\, AI and cloud base diabetes decision support tools\, and telemedicine/remote monitoring solutions. Dr. Trang Ly\, the Chief Medical Officer at Insulet\, will discuss how continuous glucose monitor (CGM) systems\, with smart AI and closed loop algorithms\, will provide patients with a worry free "artificial pancreas" that will mimic a normal pancreas\, helping keep people with diabetes in control of their blood glucose levels.\n\nAdvancements in EncapsulationCreating an environment for new beta cells to thrive\, responding to glucose and producing insulin\, and being protected from the immune system. Lastly\, Dr. Linda Tempelman\, CEO\, Giner Life Sciences\, will discuss how encapsulization devices can provide a nourishing and protected environment utilizing an oxygen delivery technology for use with a fully-implanted Type I Diabetes (T1D) cell therapy treatment employing immune-isolation capsule technology for allogenic pancreatic islets or stem-cell derived pancreatic islet-like cell clusters.\n\n\nJune 3 - Monday\nRegis College\nWeston\, MA \n\nKey insights on tackling\nthe diabetes pandemic and the\ngreat work underway to drive\ntrue advances in diabetes care\n\nEarlybird Fees by May 27 Member/Alliance Partner - $30 Non-member - $45 Student (member) - $10 Student (non-member) - $15Gold Member - No Charge Event Sponsors\nWho Should Attend: Healthcare Executives in Diabetes and Chronic DiseaseDigital/Connected HealthHealthcare AI and Support ProvidersMedical Device EntrepreneursInvestors in the MedTech Space X-ALT-DESC;FMTTYPE=text/html:

Advances in Diabetes Care

June 3 - Monday


Diabetes Clinical UpdateNew insights on both Type 1 Diabetes and Type 2 Diabetes from the perspective of a leading clinical researcher. Dr. Gabbay\, the Chief Medical Officer of the Joslin Diabetes Center\, will moderate our program\, and he will provide an overview of the best clinical practices in diabetes care today\, as well as the challenges involved in helping people with diabetes to effectively manage their diabetes.

Smart Devices and WearablesHow connected health is impacting care\, medication and insulin titration and adherence\, and clinical and economic outcomes for payers\, providers\, employers\, etc. James White\, the co-founder of Common Sensing\, a smart insulin pen company\, will describe the advances underway in using real time glucose information to help patients and their care teams to optimize diabetes management to drive better clinical and economic outcomes.

Artificial Pancreas and AIClosed loop systems\, AI and cloud base diabetes decision support tools\, and telemedicine/remote monitoring solutions. Dr. Trang Ly\, the Chief Medical Officer at Insulet\, will discuss how continuous glucose monitor (CGM) systems\, with smart AI and closed loop algorithms\, will provide patients with a worry free "\;artificial pancreas"\; that will mimic a normal pancreas\, helping keep people with diabetes in control of their blood glucose levels.

Advancements in EncapsulationCreating an environment for new beta cells to thrive\, responding to glucose and producing insulin\, and being protected from the immune system. Lastly\, Dr. Linda Tempelman\, CEO\, Giner Life Sciences\, will discuss how encapsulization devices can provide a nourishing and protected environment utilizing an oxygen delivery technology for use with a fully-implanted Type I Diabetes (T1D) cell therapy treatment employing immune-isolation capsule technology for allogenic pancreatic islets or stem-cell derived pancreatic islet-like cell clusters.



June 3 - Monday
Regis College
Weston\, MA \;

Key insights on tackling
the diabetes pandemic and the
great work underway to drive
true advances in diabetes care

Earlybird Fees by May 27 Member/Alliance Partner - $30 \;  \;Non-member - $45  \; Student (member) - $10  \; Student (non-member) - $15Gold Member - No Charge \;  \;  \;Event Sponsors

Who Should Attend: \;
  • Healthcare Executives in Diabetes and Chronic Disease
  • Digital/Connected Health
  • Healthcare AI and Support Providers
  • Medical Device Entrepreneurs
  • Investors in the MedTech Space
LOCATION:235 Wellesley Street Weston MA 02493-1545 UID:e.1244.90652 SEQUENCE:3 DTSTAMP:20191214T103814Z URL:https://business.massmedic.com/events/Details/advances-in-diabetes-care-103496?sourceTypeId=Hub END:VEVENT END:VCALENDAR